Clinical Trials

Extranodal Extension, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05805072 2023-05-06

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

Phase NA Unknown

Leukemia, Myeloid, Acute

NCT03855371 2022-11-04

PANDA-T0

Phase 1 Unknown

5 enrolled

Leukemia, Myeloid, Acute

NCT05382390 2022-05-19

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

130 enrolled

Leukemia, Myeloid, Acute

NCT05362942 2022-05-05

Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia

52 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT05320640 2022-04-11

Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors

Lymphoma, Non-Hodgkin

NCT05265962 2022-03-04

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

85 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05137886 2021-12-17

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

47 enrolled

Hodgkin Disease, Recurrence

NCT04752527 2021-11-15

Individualized Induction Therapy for Non-elderly Acute Myeloid Leukemia Patients With Adverse Risk Features

42 enrolled

Leukemia, Myeloid, Acute

NCT03257241 2021-10-01

PALG-AML1/2016

582 enrolled

Leukemia, Myeloid, Acute

NCT03080766 2021-04-28

The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype

Leukemia, Myeloid, Acute

NCT03530085 2020-12-22

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

60 enrolled

Leukemia, Myeloid, Acute

NCT04553393 2020-12-04

Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden

80 enrolled

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden

NCT04025593 2020-11-19

Biomarker Guided Treatment in DLBCL

128 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT04582604 2020-10-20

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

60 enrolled

Peripheral Blood Stem Cell Transplantation

NCT04454580 2020-09-16

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy

Unknown

15 enrolled

Leukemia, Myeloid, Acute

NCT04541277 2020-09-09

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

55 enrolled

Leukemia, Myeloid, Acute

NCT04233294 2020-08-14

Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma

Hodgkin Disease

NCT04510610 2020-08-12

Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Hodgkin Disease

NCT04279379 2020-05-07

Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

NCT03417427 2020-04-27

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Pathologic Complete Response, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04353479 2020-04-20

Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia

29 enrolled

Leukemia, Myeloid, Acute

NCT02951728 2020-03-11

DR-CHOP

58 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT04292769 2020-03-03

Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

200 enrolled

Tumor-Agnostic

Neoplasms

NCT02272478 2020-01-23

AML18

1,600 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04168138 2019-11-19

D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

Phase NA Unknown

Leukemia, Myeloid, Acute

NCT04123392 2019-10-10

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

196 enrolled

Other neoplasm

TP53

NCT04098653 2019-09-23

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

196 enrolled

Other neoplasm

Allogeneic Hematopoietic Stem Cell Transplantation

NCT04087967 2019-09-12

Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients

162 enrolled

Leukemia, Myeloid, Acute

NCT04083911 2019-09-10

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

50 enrolled

Leukemia, Myeloid, Acute

NCT04049344 2019-08-08

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

25 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT03250962 2019-04-01

SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

280 enrolled

Hodgkin Disease, Recurrence

NCT03771222 2018-12-13

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

40 enrolled

Graft vs Host Disease, Recurrence

NCT03558412 2018-09-14

A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma

LymphoidOther hematologic neoplasm

40 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03579082 2018-09-14

A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma

60 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03553537 2018-06-12

Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Lymphoma, T-Cell, Peripheral

NCT03381781 2018-01-04

Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations

Leukemia, Myeloid, Acute

NCT03256071 2017-08-21

Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

90 enrolled

Leukemia, Myeloid, Acute

NCT03026842 2017-01-20

Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)

180 enrolled

Leukemia, Myeloid, Acute

NCT02985372 2016-12-07

Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia

30 enrolled

Leukemia, Myeloid, Acute

NCT02698124 2016-03-07

PURPLE-D

Unknown

136 enrolled

Leukemia, Myeloid, Acute

NCT02685228 2016-02-18

SLOWDOSE001

Phase NA Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT01277484 2015-11-20

PODAC

Phase 1 Unknown

19 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02159820 2014-06-10

DAC and CT

500 enrolled

Other neoplasm

Primary Malignant Neoplasm of Ovary

NCT01806116 2013-03-12

DFMBHSCT

30 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01809392 2013-03-12

Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

GenitourinaryMyeloidOther hematologic neoplasm

15 enrolled

Myelodysplastic Syndromes, Wilms Tumor, Leukemia, Myeloid, Acute

NCT01133886 2010-09-03

DEC-MDS

50 enrolled